microbicides sexually transmitted infections pharmacologic agents chemical substances capable killing destroying certain microorganisms commonly cause sexually transmitted infection example human immunodeficiency virus microbicides diverse group chemical compounds exert activity variety different mechanisms action multiple compounds developed tested microbicidal activity clinical trials microbicides formulated various delivery systems including gels creams lotions aerosol sprays tablets films must used near time sexual intercourse sponges vaginal rings devices release active ingredients longer period agents developed vaginal application rectal use engaging anal sexcitation needed although many approaches preventing sexually transmitted infections general hiv particular current methods sufficient halt spread infections particularly among women people lessdeveloped nations sexual abstinence realistic option women want bear children risk sexual situations use microbicides could offer primary protection absence condoms secondary protection condom breaks slips intercourse hoped microbicides may safe effective reducing risk hiv transmission sexual activity infected citation needed detergent surfactant microbicides sodium dodecyl sulfate savvy act disrupting viral envelope capsid lipid membrane microorganisms since detergent microbicides also kill host cells impair barrier function healthy mucosal surfaces less desirable agents additionally clinical trials demonstrated agents effective preventing hiv transmissioncitation needed consequently laboratory clinical trials testing class products microbicides largely healthy vaginal ph typically quite acidic ph value around however alkaline ph semen neutralize vaginal ph one potential class microbicides acts reducing ph vaginal secretions may kill otherwise inactivate pathogenic microorganisms one agent buffergel spermicidal microbicidal gel formulated maintain natural protective acidity vagina candidates category including buffergel proven ineffective preventing hiv polyanion category microbicides includes carrageenans carrageenans family linear sulfated polysaccharides chemically related heparan sulfate many microbes utilize biochemical receptor initial attachment cell membrane thus carrageenan microbicides class act decoy receptors viral bindingcitation needed carrageenan preparations pro carraguard vaginal microbicide gels failed demonstrate efficacy preventing hiv transmission phase iii clinical multicenter trials pro demonstrated safe reduce risk hiv infection women explained mdp trial results released december similarly phase iii efficacy trial carraguard showed drug safe use ineffective preventing hiv transmission cellulose sulfate another microbicide found ineffective preventing transmission hiv february international aids society announced two phase iii trials cellulose sulfate stopped preliminary results suggested potential increased risk hiv women used satisfactory explanation application cellulose sulfate associated higher risk hiv infection placebo according review microbicide drug candidates world health organization march large number compounds early beginning year five phase iii trials testing different formulations underway vivagel sexual lubricant antiviral properties manufactured australian pharmaceutical company starpharma active ingredient nanoscale dendrimeric molecule binds viruses prevents affecting organisms experimental results vivagel indicate effectiveness blocking transmission hiv genital herpes macaque monkeys passed animaltesting phases drugapproval process australia united states followed initial human safety tests national institutes health national institute allergy infectious diseases awarded grants totaling million vivagels development testing vivagel developed standalone microbicide gel intravaginal also evaluated use condoms hoped vivagel provide extra resource mitigate subsaharan aids pandemiccitation needed also hoped microbicides block transmission hiv sexually transmitted infections caused certain human papillomaviruses hpv herpes simplex viruses hsv starpharma released results study investigating vivagels antiviral activity hiv hsv humans testing cervicovaginal samples vitro test tube compound displayed high level efficacy hiv hsv results encouraging study evaluate vivagels effect body still unknown results mean women would use product reallife settings example effect sexual intercourse semen gel often affects protective properties drug unknown caprisa trial demonstrated topical tenofovir gel provided protection researchers begun focus another class microbicides antiretroviral arv agents arvs work either preventing hiv virus entering human host cell preventing replication already examples arv drugs tested prevention include tenofovir dapivirine diarylpyrimidine inhibitor hiv reverse transcriptase nextgeneration microbicides received attention support based arv drugs currently used extend survival improve quality life hivpositive people arvs also used prevent vertical transmission hiv mother child childbirth used prevent hiv infection developing immediately exposure arvbased compounds could formulated topical microbicides administered locally rectum vagina systemically oral injectable formulations preexposure prophylaxis arvbased microbicides may formulated longacting vaginal rings gels films results first efficacy trial arvbased microbicide caprisa tested tenofovir gel form prevent maletofemale hiv transmission trial showed gel applied topically vagina effective preventing hiv caprisa microbicideefficacy study completed first demonstrate significant reduction hiv transmission results trial statistically significant offer proof concept arvs topically applied vaginal mucosa offer protection hiv first generation microbicides formulated semisolid systems gels tablets films creams designed applied vagina every act intercourse however vaginal rings potential provide longterm controlled release microbicide drugs longacting formulations like vaginal rings potentially advantageous since could easy use requiring replacement month ease use could prove important make sure products used properly international partnership microbicides began first study africa test safety acceptability vaginal ring containing drugs might also administered systemically injectable oral formulations known prep injectable formulations may desirable since could administered infrequently possibly month likely however products would need monitored closely would available prescription approach also carries risk emergence arvresistant strains substantial numbers men sex men developed countries use lubricants containing needed suggests might receptive concept using topical rectal microbicides products become commercially however development rectal microbicides advanced vaginal microbicides one reason rectum thinner epithelium greater surface area lower degree elasticity vagina due factors microbicidal preparation effective applied vaginally might different degree effectiveness applied january national institutes health awarded two grants totaling million university pittsburgh fund research rectal research include investigations product acceptability rectal microbicides homosexual men ages years oldcitation needed ultimately successful topical microbicides might simultaneously employ multiple modes action fact longacting formulations vaginal rings could provide technology needed deliver multiple active ingredients different mechanisms actioncitation needed major breakthrough microbicide research announced july reported arvbased microbicide gel could partially prevent hiv trial led centre aids programme research south africa caprisa conducted south africa demonstrated arv tenofovir used vaginal gel effective preventing hiv transmission men women july centre aids programme research south africa caprisa released results study establishing proof concept arvbased topical microbicide reduce likelihood hiv transmission trial caprisa conducted among women evaluate ability tenofovir gel prevent maletofemale hiv transmission study found lower hiv infection rate women using tenofovir gel compared women using placebo gel addition tenofovir gel shown safe results caprisa trial provide statistically significant evidence arvs topically applied vaginal mucosa offer protection hiv potentially pathogens study women used tenofovir gel acquired hiv women used placebo gel became hivinfected tenofovirresistant virus detected women acquired hiv infection study addition demonstrating efficacy hiv caprisa found evidence tenofovir gel also prevents transmission herpes simplex virus type lifelong incurable infection make infected virus twotothree times likely acquire hiv data collected caprisa study indicate tenofovir gel provided protection tenofovir developed gilead sciences nucleotide reversetranscriptase inhibitor nrti interferes replication hiv approved tablet form use combination arvs treat hiv caprisa collaboration among caprisa family health international conrad funded united states agency international development usaid south african department science technologys technology innovation agencycitation needed results released february clinical trial pro indevus pharmaceuticals vaginalmicrobicide gel sparked hope might provide modest protection results larger trial released december showed pro safe administered ineffective reducing risk hiv infection trial mdp sponsored microbicides development programme mdp conducted south africa tanzania uganda zambia women volunteers significant difference found number women contracted hiv group given pro compared group given trial result effective product served model future hivprevention trials provided scientific information lessons socialscience component community engagement preparation undertaken trial carrageenan may prevent hpv hsv transmission hiv see carrageenanmedical uses phase iii clinical trial carrageenanbased carraguard showed statistical effect hiv infection according results released study showed gel safe side effects increased risks trial also provided information usage patterns trial spermicide ineffective topical microbicide preventing hiv infection although shown increase risk hiv infection used frequently women high risk infection remains contraceptive option women low efforts underway develop safe effective topical microbicides several different gel formulations currently undergoing testing phase iii clinical efficacy trials two dozen products various phases results caprisa promising may need confirmed clinical trials microbicide tenofovir gel made available decision rests regulators particularly south africa voice study mtn another largescale trial scheduled release results voice evaluating three different strategies prevent hiv women one arvbased microbicide two regimens consisting oral arvs daily voice trial testing tenofovir vaginal gel oncedaily formulation known time voice considered confirmatory trial caprisa used different dosing products known preexposure prophylaxis prep also tested various stages development process products administered orally via injection would contain arvs protect hivnegative people becoming infected individuals would receive arvs exposed hiv goal lowering risk preventing one potential advantages prep individual could use autonomously without need negotiate partner dependent time sex hoped unable negotiate condom use sexual partners would able reduce risk hiv infection use oral injectable prophylactic drug current prep candidates development include tenofovir truvada combination two arv compounds tenofovir one potential risk prep approach drugs present systemic circulation might time create arvresistant hiv condoms effective method blocking transmission sexually transmitted infections hpv notable exceptioncitation needed however variety social factors including limited sexual disempowerment women many cultures limit feasibility condom thus topical microbicides might provide useful womaninitiated alternative condomscitation needed subsaharan african cultures view vaginal lubrication since topical microbicide formulations currently development function lubricants dry sex traditions may pose barrier implementation topical microbicidal programs recent data product acceptability however show many men women enjoy using gels sex would contain microbicidal httpsenwikipediaorgwikimicrobicidesforsexuallytransmittedinfections